» Articles » PMID: 36689432

Gene Expression Studies of WT1 Mutant Wilms Tumor Cell Lines in the Frame Work of Published Kidney Development Data Reveals Their Early Kidney Stem Cell Origin

Overview
Journal PLoS One
Date 2023 Jan 23
PMID 36689432
Authors
Affiliations
Soon will be listed here.
Abstract

In order to get a better insight into the timing of WT1 mutant Wilms tumor development, we compared the gene expression profiles of nine established WT1 mutant Wilms tumor cell lines with published data from different kidney cell types during development. Publications describing genes expressed in nephrogenic precursor cells, ureteric bud cells, more mature nephrogenic epithelial cells and interstitial cell types were used. These studies uncovered that the WT1 mutant Wilms tumor cells lines express genes from the earliest nephrogenic progenitor cells, as well as from more differentiated nephron cells with the highest expression from the stromal/interstitial compartment. The expression of genes from all cell compartments points to an early developmental origin of the tumor in a common stem cell. Although variability of the expression of specific genes was evident between the cell lines the overall expression pattern was very similar. This is likely dependent on their different genetic backgrounds with distinct WT1 mutations and the absence/presence of mutant CTNNB1.

Citing Articles

Comprehensive prognostic gene identification and functional characterization of GRAMD1A in Wilms tumor: development of risk prediction models and therapeutic implications.

Zeng Q, Tao J, Qin L, Zeng Y, Liu Z, Xu M Front Oncol. 2024; 14:1501718.

PMID: 39659787 PMC: 11628387. DOI: 10.3389/fonc.2024.1501718.


Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401.

Fasler-Kan E, Milosevic M, Ruggiero S, Aliu N, Cholewa D, Hacker F Int J Mol Sci. 2024; 25(4).

PMID: 38396958 PMC: 10889092. DOI: 10.3390/ijms25042281.


Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor.

Stevenson M, Phanor S, Patel U, Gisselbrecht S, Bulyk M, OBrien L Dis Model Mech. 2023; 16(11).

PMID: 37815464 PMC: 10668032. DOI: 10.1242/dmm.050208.


Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture.

Wojcik H, Lovvorn 3rd H, Hollingshead M, Pierce J, Stotler H, Murphy A Front Oncol. 2023; 13:1091274.

PMID: 37007076 PMC: 10061139. DOI: 10.3389/fonc.2023.1091274.

References
1.
Hu Q, Gao F, Tian W, Ruteshouser E, Wang Y, Lazar A . Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest. 2010; 121(1):174-83. PMC: 3007149. DOI: 10.1172/JCI43772. View

2.
Royer-Pokora B, Busch M, Beier M, Duhme C, de Torres C, Mora J . Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm. Hum Mol Genet. 2010; 19(9):1651-68. DOI: 10.1093/hmg/ddq042. View

3.
Gong K, Yallowitz A, Sun H, Dressler G, Wellik D . A Hox-Eya-Pax complex regulates early kidney developmental gene expression. Mol Cell Biol. 2007; 27(21):7661-8. PMC: 2169072. DOI: 10.1128/MCB.00465-07. View

4.
Davies J, Ladomery M, Hohenstein P, Michael L, Shafe A, Spraggon L . Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum Mol Genet. 2003; 13(2):235-46. DOI: 10.1093/hmg/ddh015. View

5.
Pelletier J, Schalling M, Buckler A, Rogers A, Haber D, Housman D . Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 1991; 5(8):1345-56. DOI: 10.1101/gad.5.8.1345. View